BIOMAT Database Logo BIOMAT Database Logo

23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia. 2017

Tetsuya Tanimoto, and Eiji Kusumi, and Kazutaka Hosoda, and Tamae Hamaki, and Kenzo Takahashi
Navitas Clinic, Tokyo, Japan. Electronic address: tetanimot@yahoo.co.jp.

UI MeSH Term Description Entries
D011008 Pneumococcal Infections Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE. Streptococcus pneumoniae Infections,Infections, Pneumococcal,Infections, Streptococcus pneumoniae,Pneumococcal Diseases,Disease, Pneumococcal,Diseases, Pneumococcal,Infection, Pneumococcal,Infection, Streptococcus pneumoniae,Pneumococcal Disease,Pneumococcal Infection,Streptococcus pneumoniae Infection
D011018 Pneumonia, Pneumococcal A febrile disease caused by STREPTOCOCCUS PNEUMONIAE. Pneumococcal Pneumonia,Pneumococcal Pneumonias,Pneumonias, Pneumococcal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013296 Streptococcus pneumoniae A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals. Diplococcus pneumoniae,Pneumococcus
D022242 Pneumococcal Vaccines Vaccines or candidate vaccines used to prevent infections with STREPTOCOCCUS PNEUMONIAE. Pneumococcal Polysaccharide Vaccine,Pneumococcal Vaccine,Pneumovax,Pnu-Imune Vaccine,Pnu Imune Vaccine,PnuImune Vaccine,Polysaccharide Vaccine, Pneumococcal,Vaccine, Pneumococcal,Vaccine, Pneumococcal Polysaccharide,Vaccines, Pneumococcal

Related Publications

Tetsuya Tanimoto, and Eiji Kusumi, and Kazutaka Hosoda, and Tamae Hamaki, and Kenzo Takahashi
23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia.
August 2017, The Lancet. Infectious diseases,
Tetsuya Tanimoto, and Eiji Kusumi, and Kazutaka Hosoda, and Tamae Hamaki, and Kenzo Takahashi
23-valent pneumococcal polysaccharide vaccine. WHO position paper.
October 2008, Releve epidemiologique hebdomadaire,
Tetsuya Tanimoto, and Eiji Kusumi, and Kazutaka Hosoda, and Tamae Hamaki, and Kenzo Takahashi
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study.
October 2020, PLoS medicine,
Tetsuya Tanimoto, and Eiji Kusumi, and Kazutaka Hosoda, and Tamae Hamaki, and Kenzo Takahashi
[Effectiveness of 23-valent pneumococcal polysaccharide vaccine on adult pneumococcal disease].
September 2020, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
Tetsuya Tanimoto, and Eiji Kusumi, and Kazutaka Hosoda, and Tamae Hamaki, and Kenzo Takahashi
Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013-2017.
October 2020, Emerging infectious diseases,
Tetsuya Tanimoto, and Eiji Kusumi, and Kazutaka Hosoda, and Tamae Hamaki, and Kenzo Takahashi
Effectiveness of 23-valent pneumococcal polysaccharide vaccine on diabetic elderly.
June 2016, Medicine,
Tetsuya Tanimoto, and Eiji Kusumi, and Kazutaka Hosoda, and Tamae Hamaki, and Kenzo Takahashi
Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults.
July 2003, The Journal of infectious diseases,
Tetsuya Tanimoto, and Eiji Kusumi, and Kazutaka Hosoda, and Tamae Hamaki, and Kenzo Takahashi
Incremental effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia hospitalisation among Australian Indigenous children: A record linkage study.
August 2023, Vaccine,
Tetsuya Tanimoto, and Eiji Kusumi, and Kazutaka Hosoda, and Tamae Hamaki, and Kenzo Takahashi
Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children.
January 2014, Vaccine,
Tetsuya Tanimoto, and Eiji Kusumi, and Kazutaka Hosoda, and Tamae Hamaki, and Kenzo Takahashi
Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
May 2007, Vaccine,
Copied contents to your clipboard!